StreetInsider.com News Articles

Healthcare Triangle signs LOI to acquire 51% of CosmoInnovations

Wed, 29 Jul 2026 16:10:17 -0400

Healthcare Triangle, Inc. (Nasdaq: HCTI) has signed a non-binding letter of intent to acquire a 51% equity stake in CosmoAesthetics Pty Ltd., a Melbourne, Australia-based company operating under the brand CosmoInnovations, according to a company statement.

The proposed total consideration is $23.5 million, structured through a combination of cash, equity, and performance-linked milestones over a three-year period. The transaction remains subject to due diligence, negotiation of definitive agreements, and regulatory approvals.

CosmoInnovations holds 27 granted international patents and 61 pending patent applications. The company operates across areas including skincare, photobiomodulation, respiratory wellness, oral health, pain management, and transdermal delivery. Its management projects

Healthcare Triangle signs LOI to acquire 51% of CosmoInnovations

Wed, 29 Jul 2026 16:10:17 -0400

Healthcare Triangle signs LOI to acquire 51% of CosmoInnovations

Wed, 29 Jul 2026 16:10:17 -0400

Healthcare Triangle signs LOI to acquire 51% of CosmoInnovations

Wed, 29 Jul 2026 16:10:17 -0400

Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets

Wed, 29 Jul 2026 16:10:00 -0400

Transaction introduces 27 granted international patents, 61 pending applications, and a commercial pipeline targeting over US $50 million in cumulative revenue over three years.

PLEASANTON, Calif., July 29, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for the healthcare and life sciences industries, today announced it has signed a non-binding Letter of Intent (LOI) to acquire a 51% equity stake in CosmoAesthetics Pty Ltd. Operating under the brand CosmoInnovations, the Melbourne, Australia-based company is a premier innovator

Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets

Wed, 29 Jul 2026 16:10:00 -0400

Transaction introduces 27 granted international patents, 61 pending applications, and a commercial pipeline targeting over US $50 million in cumulative revenue over three years.

Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets

Wed, 29 Jul 2026 16:10:00 -0400

Transaction introduces 27 granted international patents, 61 pending applications, and a commercial pipeline targeting over US $50 million in cumulative revenue over three years.

Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets

Wed, 29 Jul 2026 16:10:00 -0400

Transaction introduces 27 granted international patents, 61 pending applications, and a commercial pipeline targeting over US $50 million in cumulative revenue over three years.

Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets

Wed, 29 Jul 2026 16:10:00 -0400

Transaction introduces 27 granted international patents, 61 pending applications, and a commercial pipeline targeting over US $50 million in cumulative revenue over three years.

Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets

Wed, 29 Jul 2026 16:10:00 -0400

Transaction introduces 27 granted international patents, 61 pending applications, and a commercial pipeline targeting over US $50 million in cumulative revenue over three years.

Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets

Wed, 29 Jul 2026 16:10:00 -0400

Transaction introduces 27 granted international patents, 61 pending applications, and a commercial pipeline targeting over US $50 million in cumulative revenue over three years.

Healthcare Triangle Signs Non-Binding LOI to Acquire 51% of CosmoInnovations; Enters High-Growth Proprietary MedTech and Consumer-Health Markets

Wed, 29 Jul 2026 16:10:00 -0400

Transaction introduces 27 granted international patents, 61 pending applications, and a commercial pipeline targeting over US $50 million in cumulative revenue over three years.

Form 8-K Healthcare Triangle, For: Jul 28

Wed, 29 Jul 2026 07:10:00 -0400

si-local-file:///var/storage/secattach/20260729/26830487.html

Form 8-K Healthcare Triangle, For: Jul 28

Wed, 29 Jul 2026 07:10:00 -0400

si-local-file:///var/storage/secattach/20260729/26830487.html

Healthcare Triangle issues 12.5 million shares, boosting Nasdaq listing value

Wed, 29 Jul 2026 07:01:12 -0400

Healthcare Triangle, Inc. (NASDAQ: HCTI) completed the issuance of 12,546,540 shares of common stock on July 24, 2026, in connection with two previously shareholder-approved transactions: an acquisition involving Teyame AI LLC and a Share Exchange Agreement with SecureKloud Technologies Ltd.

Following the issuances, the company's total shares outstanding as of July 28, 2026, reached 14,644,322. Based on a closing stock price of $1.63 per share on that date, the company's Market Value of Listed Securities (MVLS) was approximately $23,870,244.

The share issuances come after the U.S. Securities and Exchange Commission approved a new Nasdaq continued listing requirement on July 22, 2026, establishing

Healthcare Triangle issues 12.5 million shares, boosting Nasdaq listing value

Wed, 29 Jul 2026 07:01:12 -0400

The share issuances come after the U.S. Securities and Exchange Commission approved a new Nasdaq continued listing requirement on July 22, 2026, establishing

Healthcare Triangle Completes Share Issuances Relating to Legacy M&A Transactions, Strengthening Compliance With Nasdaq's New $5 Million Market Value Listing Standard